TrialView, an AI-powered authorized tech platform, has secured a $4.1m (£3.1m) funding because it seems to be to quickly scale its headcount.
Based in 2014, TrialView is a litigation platform designed for authorized case preparation, administration and presentation.
Utilizing AI, the platform “mines” paperwork, serving to authorized groups establish and handle key proof.
The group has largely been self-funded and has claimed to have achieved $3m in annual recurring income. TrialView mentioned it’s utilized by 15 of the UK’s prime 20 regulation corporations and is now seeking to broaden into new markets, such because the US, Singapore and Australia.
“This funding is a big milestone for TrialView. It helps us promote our imaginative and prescient of serving to litigators serve their purchasers by way of more practical case preparation,” mentioned Stephen Dowling, founder and chief govt of TrialView.
“Our platform is greater than an AI software – it’s a companion for disputes groups by way of the life cycle of a case. This funding will enable us to speed up the event of our AI-driven options, broaden our group, and set up a stronger presence in key markets, together with the US.”
The funding spherical was led by Elkstone Ventures.
“TrialView has developed a really transformational platform for the authorized sector. Their group has a deep understanding of their prospects and the challenges they face, borne of their very own authorized background, constructed for practitioners by practitioners,” mentioned Niall McEvoy, managing director of enterprise at Elkstone.
“With a stellar buyer base of prime authorized corporations already utilizing the platform, we’re assured that TrialView’s software program will grow to be an indispensable software for regulation corporations globally, serving to them to maximise their effectivity, improve their authorized technique and improve their success price.”
